Format

Send to

Choose Destination
Expert Rev Anti Infect Ther. 2006 Apr;4(2):187-97.

Treatment options for visceral leishmaniasis.

Author information

1
Campaign for Access to Essential Medicines, Médecins Sans Frontières, Rue Lausanne 78 CP 116 CH-1211, Geneva 21, Switzerland. margriet.den.boer@msf.org

Abstract

This review summarizes the current developments in therapy for visceral leishmaniasis. With the recent introduction of new drugs, the main limits in reducing deaths from visceral leishmaniasis are difficulty in diagnosis in the field and health inequality--patients lack of access to treatment. No new drugs are currently in the early stages of development. There are good reasons for the use of combination therapy; to prevent further development of resistance against the limited therapeutic options available.

PMID:
16597201
DOI:
10.1586/14787210.4.2.187
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center